Total investments received (USD): 34.76m
Round value (USD): 6.91m
Round investors:
Sofinnova Partners
Company: EnginZyme
Industry:
Biotech
Health services



Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
United Kingdom